Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-27 Sale | 2024-10-01 4:13 pm | Xencor Inc | XNCR | ROSA-BJORKESON DAGMAR Director | 2,503 | $20.68 | $51,762 | 8,490 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-13 Option Award | 2024-06-17 4:24 pm | N/A 2034-06-12 | Xencor Inc | XNCR | ROSA-BJORKESON DAGMAR Director | 17,957 | $0 | 22,964 (Direct) | View |
| 2023-11-08 Disposition | 2023-11-13 2:43 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director | 43,056 | $0 | 0 (Direct) | View |
| 2023-11-08 Disposition | 2023-11-13 2:43 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director | 11,625 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:43 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director | 14,766 | $19 | 0 (Direct) | View |
| 2023-06-20 Option Award | 2023-06-22 5:52 pm | N/A 2033-06-20 | Xencor Inc | XNCR | ROSA-BJORKESON DAGMAR Director | 15,020 | $0 | 15,020 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:39 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director | 20,658 | $0 | 38,938 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:49 pm | N/A 2032-06-23 | Xencor Inc | XNCR | ROSA-BJORKESON DAGMAR Director | 21,412 | $0 | 21,412 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 4:16 pm | N/A 2032-05-25 | INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director | 20,527 | $0 | 31,070 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-25 8:00 pm | N/A 2031-06-24 | Xencor Inc | XNCR | ROSA-BJORKESON DAGMAR Director | 9,728 | $0 | 9,728 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-01 7:01 pm | N/A 2031-05-27 | INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director | 28,262 | $0 | 28,262 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 8:49 pm | N/A 2030-06-24 | Xencor Inc | XNCR | ROSA-BJORKESON DAGMAR Director | 13,953 | $0 | 13,953 (Direct) | View |
| 2019-12-18 Option Award | 2019-12-20 5:16 pm | N/A 2029-12-17 | Xencor Inc | XNCR | ROSA-BJORKESON DAGMAR Director | 15,528 | $0 | 15,528 (Direct) | View |